Share Capital (Tables)

12 Months Ended

Dec. 31, 2017

Share Based Compensation Allocation And Classification In Financial Statements [Abstract]

Schedule of Share Capital

Share capital is composed as follows:

	Issued and outstanding
	Number of shares
	December 31,
	2017		2016
Ordinary shares no par value		89,478,032		87,066,446

Schedule of Warrants to Purchase Ordinary Shares were Issued to Purchase of Convertible Preferred Shares

Significant terms of the warrants to purchase ordinary shares that were issued to purchasers of the Series D and E Convertible Preferred shares are as follows as of December 31, 2017 and 2016:

	Warrants for ordinary shares
	December 31,				Exercise price
Expiration date	2017		2016		per share
July 31, 2017		-		547,478	$	3.59
January 22, 2018		203,241		554,331		3.59
July 21, 2018		304,863		831,504	$	3.59
		508,104		1,933,313

In the years ended December 31, 2017 and 2016, warrants to purchase 1,418,711 and 902,132 ordinary shares, respectively, were cashlessly exercised, resulting in the issuance of 803,138 and 864,341 ordinary shares, respectively. Also, in the year ended December 31, 2017 and 2016 warrants to purchase 6,498 and 220,316 ordinary shares, respectively, with an exercise price of $3.59 per share were exercised for cash

Schedule of Fair Value Assumptions Used for All Equity Based Awards Estimated Using Black-Scholes Option Pricing Model

The fair value of share-based awards was estimated using the Black-Scholes model for all equity grants. For market condition awards, the Company also applied the Monte-Carlo simulation model, with the following underlying assumptions:

	Year ended December 31,
	2017	2016	2015
Stock Option Plans
Expected term (years)	5.50-6.25	6.25	6.25
Expected volatility	56.74%-59.45%	58.4%-61.70%	59.0%-65.80%
Risk-free interest rate	1.97%-2.23%	1.23%-1.88%	1.74%-2.05%
Dividend yield	0.00%	0.00%	0.00%
ESPP
Expected term (years)	0.50	0.42		-
Expected volatility	76.37%-82.00%	70.45%		-
Risk-free interest rate	0.62%-1.13%	0.4%		-
Dividend yield	0.00%	0.00%		-

Schedule of Stock Options to Purchase Ordinary Shares

A summary of the status of the Company’s options to purchase ordinary shares as of December 31, 2017 and changes during the year ended on that date is presented below:

	Year ended December 31, 2017
	Number of options			Weighted average exercise price		Aggregate intrinsic value
Outstanding at beginning of year		11,377,354		$	9.76
Granted		5,381,613		$	10.53
Exercised		(1,442,522	)	$	2.64
Forfeited and cancelled		(510,418	)	$	12.54
Outstanding at end of year		14,806,027		$	10.64	$	145,755
Exercisable options		6,389,813		$	8.64		75,547

Schedule of RSUs

A summary of the status of the Company’s RSUs as of December 31, 2017 and changes during the year ended on that date is presented below:

	Year ended December 31, 2017
	Number of RSUs			Weighted average grant date fair value price		Aggregate intrinsic value
Unvested at beginning of year	-			$	-
Granted		1,661,619			9.64
Vested	-				-
Forfeited and cancelled		(10,400	)		7.15
Unvested as of December 31, 2017		1,651,219		$	9.66	$	33,354

Schedule of Equity-Based Compensation Expenses Related to Company's Equity-Based Awards

The total equity-based compensation expense related to all of the Company’s equity-based awards recognized for the years ended December 31, 2017, 2016 and 2015, was comprised as follows:

	Year ended December 31,
	2017		2016		2015
Cost of revenues	$	467	$	623	$	174
Research, development and clinical trials		3,587		3,155		2,529
Sales and marketing		3,784		5,111		2,496
General and administrative		19,278		12,552		6,661
Total share-based compensation expense	$	27,116	$	21,441	$	11,860

Schedule of Stock Option Outstanding

The options outstanding as of December 31, 2017 are as follows:

Exercise price	Number of options outstanding		Weighted average remaining contractual term		Number of options exercisable		Weighted average remaining contractual term
$			(years)				(years)
0.23 - 1.00		338,906		1.95		338,906		1.95
1.01 - 7.00		2,627,476		4.29		2,491,388		4.05
7.01 - 11.00		4,395,057		7.56		1,589,345		5.20
11.01 - 16.00		5,260,210		8.21		1,305,796		6.94
16.01 - 20.00		351,750		9.57		-		-
20.01 - 27.50		1,832,628		8.15		664,378		7.83
		14,806,027		7.20		6,389,813		5.21